Download Citation
Article Source:
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study
Gori S,
Inno A,
Rossi V,
Turazza M,
Fiorio E,
et al.
(2016)
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
PLOS ONE 11(5): e0156221.
https://doi.org/10.1371/journal.pone.0156221